Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

CUSIP: 03843E104

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
120,192,308
Total 13F shares
43,378,481
Share change
-3,458,097
Total reported value
$154,428,036
Put/Call ratio
29%
Price per share
$3.56
Number of holders
113
Value change
-$13,648,629
Number of buys
59
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2024

As of 31 Dec 2024, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,378,481 shares. The largest 10 holders included Bratton Capital Management, L.P., BlackRock, Inc., VANGUARD GROUP INC, VR Adviser, LLC, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, MPM BIOIMPACT LLC, STATE STREET CORP, Janney Montgomery Scott LLC, and Blue Owl Capital Holdings LP. This page lists 113 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.